These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4378228)

  • 21. Tests for amyloidosis.
    Br Med J; 1968 Nov; 4(5630):564-5. PubMed ID: 5722322
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cardiac amyloidosis: review of the literature].
    Gouveia D; Carranca J; Lousada N; Adão M; Ferreira T; Pereira T; Correia M
    Rev Port Cardiol; 1996 Sep; 15(9):657-64, 613. PubMed ID: 9081319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple myeloma-associated amyloidosis is an independent high-risk prognostic factor.
    Vela-Ojeda J; García-Ruiz Esparza MA; Padilla-González Y; Sánchez-Cortes E; García-Chávez J; Montiel-Cervantes L; Reyes-Maldonado E; Majluf-Cruz A; Mayani H
    Ann Hematol; 2009 Jan; 88(1):59-66. PubMed ID: 18648809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical aspects of renal amyloidosis].
    Mukhin NA
    Klin Med (Mosk); 1983 Oct; 61(10):12-7. PubMed ID: 6645318
    [No Abstract]   [Full Text] [Related]  

  • 25. Primary amyloidosis. Recognition and management.
    Cohen AS
    Hosp Pract (Off Ed); 1986 Jan; 21(1A):29-35, 38-9. PubMed ID: 3080458
    [No Abstract]   [Full Text] [Related]  

  • 26. [The problem of amyloidosis in rheumatic diseases].
    Dilşen N; Ulagay I
    Turk Tip Cemiy Mecm; 1968; 34(11):671-81. PubMed ID: 5306477
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diagnostics and therapy of amyloidosis].
    Pettersson T; Törnroth T; Maury P
    Duodecim; 1999; 115(11):1201-11. PubMed ID: 11877839
    [No Abstract]   [Full Text] [Related]  

  • 28. [Primary localized bladder amyloidosis].
    Haouas N; Colas JM
    Rev Med Suisse; 2007 May; 3(112):1334-6. PubMed ID: 17596070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloidosis: current approaches for diagnosis and treatment.
    Reed SB; Morris GT
    J Ky Med Assoc; 1992 Feb; 90(2):68-72. PubMed ID: 1597673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic options in systemic AL amyloidosis.
    van Gameren II; Lokhorst H; Hazenberg BP; Vellenga E
    Neth J Med; 2004 Apr; 62(4):106-13. PubMed ID: 15255079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac amyloidosis: approaches to diagnosis and management.
    Desai HV; Aronow WS; Peterson SJ; Frishman WH
    Cardiol Rev; 2010; 18(1):1-11. PubMed ID: 20010333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the modified bennhold test in the diagnosis of amyloidosis associated with rheumatoid arthritis (author's transl)].
    Handlova D; Kutova M
    Schweiz Rundsch Med Prax; 1974 Jul; 63(28):875-7. PubMed ID: 4409511
    [No Abstract]   [Full Text] [Related]  

  • 33. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis.
    Sato H; Kuroda T; Tanabe N; Ajiro J; Wada Y; Murakami S; Sakatsume M; Nakano M; Gejyo F
    Scand J Rheumatol; 2010; 39(1):33-7. PubMed ID: 20132068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the basics of primary systemic amyloidosis.
    Schumacher DL
    J Contin Educ Nurs; 2004; 35(1):15-6. PubMed ID: 14870905
    [No Abstract]   [Full Text] [Related]  

  • 35. Diagnostic and therapeutic approach of systemic amyloidosis.
    Hazenberg BP; van Gameren II; Bijzet J; Jager PL; van Rijswijk MH
    Neth J Med; 2004 Apr; 62(4):121-8. PubMed ID: 15255082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary systemic amyloidosis: clinical and laboratory features in 474 cases.
    Kyle RA; Gertz MA
    Semin Hematol; 1995 Jan; 32(1):45-59. PubMed ID: 7878478
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnosis and therapy for beta2-microglobulin amyloidosis in the K/DOQI guideline].
    Higuchi N; Maruyama H
    Clin Calcium; 2004 May; 14(5):744-9. PubMed ID: 15577036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and biochemical outcome of renal amyloidosis.
    Odabas AR; Cetinkaya R; Selcuk Y; Erman Z; Bilen H
    Int J Clin Pract; 2002 Jun; 56(5):342-4. PubMed ID: 12137441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contribution of myocardial biopsy and immunohistochemistry to the prognostic evaluation of cardiac amyloidosis].
    Van de Walle JP; Fourcade L; Panagides D; Harle JR; Pellissier JF; Touze JE; Bory M
    Arch Mal Coeur Vaiss; 1994 Feb; 87(2):235-9. PubMed ID: 7802531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary, systemic amyloidosis and the dermatologist: where classic skin lesions may provide the clue for early diagnosis.
    Silverstein SR
    Dermatol Online J; 2005 Mar; 11(1):5. PubMed ID: 15748546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.